banner

GST : 27AEUPJ3828B1ZE

400 MG Bevacizumab Injection
400 MG Bevacizumab Injection

400 MG Bevacizumab Injection

MOQ : 1 Unit

400 MG Bevacizumab Injection Specification

  • Dosage Form
  • Injection
  • Indication
  • Cancer (Colorectal, Lung, Glioblastoma, Renal Cell Carcinoma, Cervical Cancer, Ovarian Cancer)
  • Salt Composition
  • Bevacizumab 400 mg
  • Feature
  • Sterile and pyrogen-free, ready to use, single dose vial
  • Ingredients
  • Bevacizumab (concentrate for solution), excipients including trehalose, polysorbate 20, sodium phosphate, water for injection
  • Application
  • Intravenous infusion
  • Ph Level
  • 6.2
  • Physical Color/Texture
  • Clear to slightly opalescent, colorless to pale brown liquid
  • Storage Instructions
  • Dry place
  • Shelf Life
  • 24 Months
  • Strength
  • 400 mg/16 mL (25 mg/mL)
  • Prescription/Non Prescription
  • Prescription
  • Caution
  • Administer under medical supervision only
  • Route of Administration
  • Intravenous (IV) infusions only
  • Packaging Type
  • Single-use vial
 

400 MG Bevacizumab Injection Trade Information

  • Minimum Order Quantity
  • 1 Unit
  • Payment Terms
  • Cash Advance (CA)
  • Supply Ability
  • 5000 Units Per Month
  • Delivery Time
  • 5-7 Days
  • Main Export Market(s)
  • Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
 

About 400 MG Bevacizumab Injection



Presenting the 400 MG Bevacizumab Injection-an unmatchable solution for modern oncology care. This first-rate, sterile, and pyrogen-free product comes in a convenient single-use vial, ensuring optimal safety and efficacy. Popular as a best-seller among medical professionals, it is indicated for several cancers including colorectal, lung, glioblastoma, renal cell carcinoma, cervical, and ovarian. Featuring a clear, cost-effective formula with a glorious 24-month shelf life, this injection is strictly for intravenous use under prescription and medical supervision. Store in a dry place for maintained potency. Available for export, supply, and trade from India.

Expansive Therapeutic Area & Advanced Features

The 400 MG Bevacizumab Injection is primarily utilized for intravenous treatment of multiple malignant cancers, including colorectal, lung, glioblastoma, renal cell carcinoma, cervical, and ovarian cancer. As a ready-to-use single-dose vial, it prioritizes patient safety and convenience. Sterile, pyrogen-free, and featuring an optimized pH level of 6.2, it combines reliability and efficacy in every infused dose. Only prescribed and administered by professionals, it is tailored for use in advanced medical settings.


Sample Availability & Reliable Supply Protocols

We offer sample handover for quality assurance prior to bulk orders of the 400 MG Bevacizumab Injection. Secure payment terms are in place to ensure a smooth transaction. With robust supply ability, our goods are carefully dispatched and timely shipped, maintaining compliance with all pharmaceutical regulations. Every vial is managed with care from handover to delivery, solidifying our commitment to trusted, efficient pharmaceutical logistics.


FAQ's of 400 MG Bevacizumab Injection:


Q: How should the 400 MG Bevacizumab Injection be administered?

A: This injection must be given as an intravenous (IV) infusion under the direct supervision of a healthcare professional, strictly via prescription.

Q: What types of cancer is this injection indicated for?

A: It is indicated for colorectal, lung, glioblastoma, renal cell carcinoma, cervical, and ovarian cancers, among others.

Q: When should Bevacizumab Injection be stored and at what conditions?

A: Store the vial in a dry place under recommended storage conditions to maintain its efficacy throughout the 24-month shelf life.

Q: Where is this product available for export or supply?

A: The 400 MG Bevacizumab Injection is available for export, supply, and trading, with operations based in India.

Q: What are the key features of this injection formulation?

A: This product is a sterile, pyrogen-free concentrate that is ready-to-use, presented in a clear, colorless to pale brown, single-use vial.

Q: What is the process of sample handover and shipping for bulk orders?

A: Samples can be provided before placing large orders. Shipped goods are dispatched promptly, ensuring compliance and efficient delivery.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anti Cancer Injection Category

400 MG Tocilizumab Injection

400 MG Tocilizumab Injection

Minimum Order Quantity : 10 Boxes

Shelf Life : 24 Months

Physical Color/Texture : Other , Clear to opalescent, colorless to pale yellow solution

Salt Composition : Tocilizumab 400 mg

Ingredients : Other , Tocilizumab

Dosage Form : Injection

Recombinant Human Injection 4000 IU

Recombinant Human Injection 4000 IU

Minimum Order Quantity : 10 Units

Shelf Life : 24 months from date of manufacture

Physical Color/Texture : Other , Clear, colorless or slightly yellow liquid

Salt Composition : Recombinant Human Erythropoietin Alfa (4000 IU) rHuEPO

Ingredients : Other , Recombinant human erythropoietin alfa, excipients, solvent for injection

Dosage Form : Injection

100 MG Oxaliplatin Solucion Injectable

100 MG Oxaliplatin Solucion Injectable

Minimum Order Quantity : 10 Units

Shelf Life : 2 years

Physical Color/Texture : Other , Clear, colorless solution

Salt Composition : Oxaliplatin 100 mg/50 ml (2 mg/ml)

Ingredients : Other , Active: Oxaliplatin; Excipients: Water for Injections

Dosage Form : Injectable Solution

50 MG Doxorubicin Injection IP

50 MG Doxorubicin Injection IP

Minimum Order Quantity : 10 Units

Shelf Life : 36 months

Physical Color/Texture : Other , Clear red solution

Salt Composition : Doxorubicin Hydrochloride 50 mg

Ingredients : Other , Doxorubicin Hydrochloride, Water for Injection, Excipients

Dosage Form : Injection



Back to top